Resultados de Búsqueda por Autor

1

artículo

An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of Liver

Publicado por
Chávez-Tapia, Norberto, Ridruejo, Ezequiel, Alves de Mattos, Angelo, Bessone, Fernando, Daruich, Jorge, Sánchez-Ávila, Juan, Cheinquer, Hugo, Zapata, Rodrigo, Uribe, Misael, Bosques-Padilla, Francisco, Gadano, Adrián, Soza, Alejandro, Dávalos-Moscol, Milagros, Marroni, Claudio, Muñoz-Espinoza, Linda, Castro-Narro, Graciela, Paraná, Raymundo, Méndez-Sánchez, Nahum

Publicado 2013

Enlace

La hepatitis C es una causa común de enfermedad hepática en etapa terminal, y la principal indicación para el trasplante de hígado en América Latina. El tratamiento de los pacientes infectados con hepatitis C mejora los resultados considerablemente a largo plazo como la mortalidad. La respuesta viral sostenida se alcanza en cerca del 50% de los pacientes con el tratamiento previo basado en interferón pegilado y ribavirina. Recientemente, se dispone de nuevos medicamentos que aumentan significativamente la respuesta viral sostenida, cambiando el estándar de atención a la terapia triple. Esta guía proporciona al profesional de la salud de Latinoamérica un marco de referencia para el manejo de pacientes con infección crónica por hepatitis C.

2

artículo

An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

Publicado por
Chávez-Tapia, Norberto C., Ridruejo, Ezequiel, Alves de Mattos, Angelo, Bessone, Fernando, Daruich, Jorge, Sánchez-Ávila, Juan F., Cheinquer, Hugo, Zapata, Rodrigo, Uribe, Misael, Bosques-Padilla, Francisco, Gadano, Adrián, Sosa, Alejandro, Dávalos-Moscol, Milagros, Marroni, Claudio, Muñoz-Espinoza, Linda, Castro-Narro, Graciela, Paraná, Raymundo, Méndez-Sánchez, Nahum, Latin American Association for the Study of the Liver

Publicado 2013

Enlace

Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is reached in near 50% of patients with the previous management based in pegylated interferon and ribavirin. Recently new drugs were available increasing sustained viral response significantly, changing the standard of care to triple therapy. This guidelines provides a framework for practitioner in Latin America, to the management of patients with hepatitis C chronic infection.

3

artículo

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease

Publicado por
Arab, Juan Pablo, Dirchwolf, Melisa, Álvares-da-Silva, Mário Reis, Barrera, Francisco, Benítez, Carlos, Castellanos-Fernandez, Marlene, Castro-Narro, Graciela, Chavez-Tapia, Norberto, Chiodi, Daniela, Cotrim, Helma, Cusi, Kenneth, de Oliveira, Claudia Pinto Marques Souza, Díaz, Javier, Fassio, Eduardo, Gerona, Solange, Girala, Marco, Hernandez, Nelia, Marciano, Sebastián, Masson, Walter, Méndez-Sánchez, Nahum, Leite, Nathalie, Lozano, Adelina, Padilla, Martín, Panduro, Arturo, Paraná, Raymundo, Parise, Edison, Perez, Marlene, Poniachik, Jaime, Restrepo, Juan Carlos, Ruf, Andrés, Silva, Marcelo, Tagle, Martín, Tapias, Monica, Torres, Kenia, Vilar-Gomez, Eduardo, Costa Gil, José Eduardo, Gadano, Adrian, Arrese, Marco

Publicado 2020

Enlace

Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitantly with the global epidemic of obesity, type 2 diabetes mellitus (T2DM), and sedentary lifestyle. NAFLD is a clinical syndrome that encompasses a wide spectrum of associated diseases and hepatic complications such as hepatocellular carcinoma (HCC). Moreover, this disease is believed to become the main indication for liver transplantation in the near future. Since NAFLD management represents a growing challenge for primary care physicians, the Asociación Latinoamericana para el Estudio del Hígado (ALEH) has decided to organize this Practice Guidance for the Diagnosis and Treatment of Non-Alcoholic F...

4

artículo

OP-4 Implementation of a re-linkage to care strategy in patients with chronic hepatitis c who were lost to follow-up in Latin America

Publicado por
Mendizabal, Manuel, Thompson, Marcos, Gonzalez Ballerga, Esteban, Anders, Margarita, Castro Narro, Graciela E., Pessoa, Mario G, Cheinquer, Hugo, Mezzano, Gabriel, Palazzo, Ana, Ridruejo, Ezequiel, Descalzi, Valeria, Velarde-Ruiz Velasco, Jose A., Marciano, Sebastian, Muñoz, Linda, Schinoni, Maria I., Poniachik, Jaime, Perazzo, Rosalía, Cerda, Eira, Fuster, Francisco, Varon, Adriana, García Ruiz, Sandro, Soza, Alejandro, Cabrera, Cecilia, Gomez Aldana, Andres J, Beltrán, Flor de María, Gerona, Solange, Cocozzella, Daniel, Bessone, Fernando, Hernández, Nelia, Alonso, Cristina, Ferreiro, Melina, Antinucci, Florencia, Torre, Aldo, Moutinho, Bruna D., Borges, Silvia Coelho, Gomez, Fernando, Murga, Maria Dolores, Piñero, Federico, Sotera, Gisela F, Ocampo, Jhonier A., Mollinedo, Valeria A Cortés, Girala, Marcos, Montes, Pedro, Ratusnu, Natalia, Zuñagua, Claudia A., Castillo, Lida, Barradas, Mauricio Castillo, Chávez, Rocío, Ivantes, Cláudia, Brutti, Julia, Tenorio, Laura, Garavito, Jorge, Zevallos, Katherine, Contreras, Fernando, Infante, Mirtha, Vera-Pozo, Emilia, Tagle, Martín, Toro, Luis G., De La Rocha, Carlos A., Simian, Daniela, Silva, Marcelo O.

Publicado 2023

Enlace

Aproximadamente 1 de cada 4 pacientes con VHC crónico que eran LTFU eran candidatos para recibir tratamiento. Esta estrategia tiene el potencial de ser efectiva y accesible y tiene un impacto significativo en la cascada de atención del VHC.